REN and obesity due to melanocortin 4 receptor deficiency: In this regard, dysregulation of the natriuretic peptide (NP) system and inappropriate activation of the Renin–Angiotensin–Aldosterone System (RAAS) contribute to the development of obesity-associated DD in the absence of significant impairment in EF, a marker of systolic dysfunction [13–18].